| Name | Title | Contact Details |
|---|---|---|
Jason Daly |
Executive Vice President | Chief Legal Officer | Profile |
Meredith Cook |
Vice President and Associate General Counsel | Profile |
Stephen Manzano |
Senior Vice President, General Counsel and Secretary | Profile |
Leslie Restaino |
Chief Compliance Officer | Profile |
Christa Haskins |
Associate Director, E-Discovery | Profile |
Conceptis Technologies Inc is a Montral, QC-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
International Stem Cell Corporation is a Oceanside, CA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Stason Pharmaceuticals Inc is a Irvine, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
BHE is an independent health analytics company with over two decades of experience in designing and conducting research that assesses the value of medical technologies.
The Ripple Therapeutics Epidel® technology is founded on a discovery that drugs can be engineered into controlled release materials without the use of polymers or excipients. The proprietary prodrugs are new chemical entities (NCEs) that have unique properties that allow them to be processed into standalone drug delivery implants (e.g. intravitreal implants, micro/nanoparticles, etc.) or as coatings on medical devices. Ripple Therapeutics implants and coatings are made up entirely from the prodrug without a polymeric carrier to control the implant or drug release properties. The implants and coatings undergo surface erosion to give zero order drug release profiles and are highly engineerable (e.g. different forms, shapes, and sizes) to tailor drug dose and duration for the specific indication of interest. The flexibility in molecular design results in drug doses that are within the therapeutic window, delivering the right amount of drug for the right amount of time. This has the potential to improve patient safety and clinical outcomes.